Bazel International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:53 pm

Quick Insight

Bazel International Ltd, a Non-Banking Financial Company (NBFC), currently trades at a price of 60.0 with a market capitalization of 15.4 Cr. The company's financial metrics reveal a P/E ratio of 6.70, ROE of 3.04%, ROCE of 3.78%, and an impressive OPM of 76.92%. With a net profit of 1.45 Cr and reserves standing at 48.11 Cr, Bazel International's financial health seems stable. However, the firm's low P/BV ratio of 0.43x and a CCC of 1,215.91 days warrant further scrutiny, suggesting potential liquidity and asset valuation concerns. Investors should closely monitor the company's ability to efficiently manage its working capital and leverage to ensure sustained growth and profitability in the long term.

Competitors of Bazel International Ltd

All Competitor Stocks of Bazel International Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:35 pm

Below is a detailed analysis of the quarterly data for Bazel International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.43 Cr. (Mar 2025) to 1.04 Cr., marking a decrease of 1.39 Cr..
• For Expenses, as of Jun 2025, the value is 0.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.36 Cr. (Mar 2025) to 0.24 Cr., marking a decrease of 1.12 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.80 Cr.. The value appears to be declining and may need further review. It has decreased from 1.07 Cr. (Mar 2025) to 0.80 Cr., marking a decrease of 0.27 Cr..
• For OPM %, as of Jun 2025, the value is 76.92%. The value appears strong and on an upward trend. It has increased from 44.03% (Mar 2025) to 76.92%, marking an increase of 32.89%.
• For Other Income, as of Jun 2025, the value is 0.06 Cr.. The value appears to be declining and may need further review. It has decreased from 0.85 Cr. (Mar 2025) to 0.06 Cr., marking a decrease of 0.79 Cr..
• For Interest, as of Jun 2025, the value is 0.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.34 Cr. (Mar 2025) to 0.23 Cr., marking a decrease of 0.11 Cr..
• For Depreciation, as of Jun 2025, the value is 0.03 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.10 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.07 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 1.48 Cr. (Mar 2025) to 0.60 Cr., marking a decrease of 0.88 Cr..
• For Tax %, as of Jun 2025, the value is 26.67%. The value appears to be improving (decreasing) as expected. It has decreased from 33.11% (Mar 2025) to 26.67%, marking a decrease of 6.44%.
• For Net Profit, as of Jun 2025, the value is 0.44 Cr.. The value appears to be declining and may need further review. It has decreased from 0.99 Cr. (Mar 2025) to 0.44 Cr., marking a decrease of 0.55 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.71. The value appears to be declining and may need further review. It has decreased from 3.86 (Mar 2025) to 1.71, marking a decrease of 2.15.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:38 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:44 pm

Below is a detailed analysis of the balance sheet data for Bazel International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 3.38 Cr.. The value appears strong and on an upward trend. It has increased from 1.95 Cr. (Mar 2024) to 3.38 Cr., marking an increase of 1.43 Cr..
• For Reserves, as of Mar 2025, the value is 48.11 Cr.. The value appears strong and on an upward trend. It has increased from 41.98 Cr. (Mar 2024) to 48.11 Cr., marking an increase of 6.13 Cr..
• For Borrowings, as of Mar 2025, the value is 19.21 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 8.72 Cr. (Mar 2024) to 19.21 Cr., marking an increase of 10.49 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1.03 Cr.. The value appears to be improving (decreasing). It has decreased from 2.91 Cr. (Mar 2024) to 1.03 Cr., marking a decrease of 1.88 Cr..
• For Total Liabilities, as of Mar 2025, the value is 71.73 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 55.56 Cr. (Mar 2024) to 71.73 Cr., marking an increase of 16.17 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.19 Cr.. The value appears to be declining and may need further review. It has decreased from 0.32 Cr. (Mar 2024) to 0.19 Cr., marking a decrease of 0.13 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 11.29 Cr.. The value appears strong and on an upward trend. It has increased from 2.89 Cr. (Mar 2024) to 11.29 Cr., marking an increase of 8.40 Cr..
• For Other Assets, as of Mar 2025, the value is 60.25 Cr.. The value appears strong and on an upward trend. It has increased from 52.35 Cr. (Mar 2024) to 60.25 Cr., marking an increase of 7.90 Cr..
• For Total Assets, as of Mar 2025, the value is 71.73 Cr.. The value appears strong and on an upward trend. It has increased from 55.56 Cr. (Mar 2024) to 71.73 Cr., marking an increase of 16.17 Cr..

Notably, the Reserves (48.11 Cr.) exceed the Borrowings (19.21 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Bazel International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 7.59, marking an increase of 5.72.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 7.59, marking an increase of 5.72.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.36. This value is below the healthy minimum of 3. It has decreased from 2.49 (Mar 24) to 1.36, marking a decrease of 1.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 152.37. It has decreased from 225.24 (Mar 24) to 152.37, marking a decrease of 72.87.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 152.37. It has decreased from 225.24 (Mar 24) to 152.37, marking a decrease of 72.87.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.48. It has decreased from 91.19 (Mar 24) to 9.48, marking a decrease of 81.71.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.80. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 4.80, marking an increase of 0.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.41. This value is within the healthy range. It has increased from 3.70 (Mar 24) to 4.41, marking an increase of 0.71.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.65. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.65, marking an increase of 0.25.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 2. It has decreased from 1.82 (Mar 24) to 0.97, marking a decrease of 0.85.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.25. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 2.25, marking an increase of 0.43.
• For PBDIT Margin (%), as of Mar 25, the value is 50.57. This value is within the healthy range. It has increased from 4.79 (Mar 24) to 50.57, marking an increase of 45.78.
• For PBIT Margin (%), as of Mar 25, the value is 46.50. This value exceeds the healthy maximum of 20. It has increased from 4.06 (Mar 24) to 46.50, marking an increase of 42.44.
• For PBT Margin (%), as of Mar 25, the value is 27.97. This value is within the healthy range. It has increased from 2.63 (Mar 24) to 27.97, marking an increase of 25.34.
• For Net Profit Margin (%), as of Mar 25, the value is 10.28. This value exceeds the healthy maximum of 10. It has increased from 1.99 (Mar 24) to 10.28, marking an increase of 8.29.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 23.76. This value exceeds the healthy maximum of 20. It has increased from 1.99 (Mar 24) to 23.76, marking an increase of 21.77.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 15. It has increased from 0.80 (Mar 24) to 1.47, marking an increase of 0.67.
• For Return on Capital Employeed (%), as of Mar 25, the value is 2.85. This value is below the healthy minimum of 10. It has increased from 1.59 (Mar 24) to 2.85, marking an increase of 1.26.
• For Return On Assets (%), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 5. It has increased from 0.63 (Mar 24) to 1.05, marking an increase of 0.42.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 0.37, marking an increase of 0.18.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Current Ratio (X), as of Mar 25, the value is 3.50. This value exceeds the healthy maximum of 3. It has decreased from 5.24 (Mar 24) to 3.50, marking a decrease of 1.74.
• For Quick Ratio (X), as of Mar 25, the value is 3.50. This value exceeds the healthy maximum of 2. It has decreased from 5.24 (Mar 24) to 3.50, marking a decrease of 1.74.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 3. It has decreased from 3.35 (Mar 24) to 2.73, marking a decrease of 0.62.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 3. It has decreased from 2.40 (Mar 24) to 1.55, marking a decrease of 0.85.
• For Enterprise Value (Cr.), as of Mar 25, the value is 37.36. It has increased from 15.52 (Mar 24) to 37.36, marking an increase of 21.84.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.89. This value exceeds the healthy maximum of 3. It has increased from 0.87 (Mar 24) to 12.89, marking an increase of 12.02.
• For EV / EBITDA (X), as of Mar 25, the value is 25.48. This value exceeds the healthy maximum of 15. It has increased from 18.20 (Mar 24) to 25.48, marking an increase of 7.28.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.00. This value exceeds the healthy maximum of 3. It has increased from 0.47 (Mar 24) to 7.00, marking an increase of 6.53.
• For Price / BV (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 24) to 0.43, marking an increase of 0.24.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.00. This value exceeds the healthy maximum of 3. It has increased from 0.47 (Mar 24) to 7.00, marking an increase of 6.53.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness